Skip to Content

Global Pharmatech Inc - Stock Quote GBLP

Rating as of

Morningstar's Global Pharmatech Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - GBLP

Global Pharmatech Inc's Company Profile

Business Description

Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and advanced R&D technologies. Geographically, the major business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.

No. 75, Fa Yuen Street, Mong Kok, Flat/RM 705, 7/F, Fa Yuen Commercial Building
Hong Kong, Hong Kong
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2008
Fiscal Year End Dec 31, 2022
Stock Type Distressed
Employees 217